Karras Nolan E. 4

Accession 0001415889-20-001371

CIK 0000856982other

View on SEC.gov Company Profile

Filed

May 28, 8:00 PM ET

Accepted

May 29, 3:46 PM ET

Size

24.9 KB

Accession

0001415889-20-001371

Insider Transaction Report

Form 4

Period: 2020-05-27

MERIT MEDICAL SYSTEMS INCMMSI

Karras Nolan E.

Director

Transactions

Exercise/Conversion
Non-qualified stock options (right to buy)
2020-05-28−5,000→ 15,000 total
Exercise: $13.99From: 2015-06-11Exp: 2021-06-11→ Common Stock (5,000 underlying)
Sale
Common Stock, No Par Value
2020-05-27$44.12/sh−5,000$220,600→ 10,500 total
Exercise/Conversion
Common Stock, No Par Value
2020-05-27$13.99/sh+5,000$69,950→ 15,500 total
Sale
Common Stock, No Par Value
2020-05-28$43.87/sh−5,000$219,350→ 10,500 total
Exercise/Conversion
Non-qualified stock options (right to buy)
2020-05-27−5,000→ 20,000 total
Exercise: $13.99From: 2015-06-11Exp: 2021-06-11→ Common Stock (5,000 underlying)
Exercise/Conversion
Common Stock, No Par Value
2020-05-28$13.99/sh+5,000$69,950→ 15,500 total

Holdings

Common Stock, No Par Value
(indirect: By Trust)
2,000
Non-qualified stock options (right to buy)
Exercise: $18.80From: 2017-05-26Exp: 2023-05-26→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $52.17From: 2020-05-24Exp: 2026-05-24→ Common Stock (13,750 underlying)
13,750
Common Stock, No Par Value
(indirect: By IRA)
4,000
Non-qualified stock options (right to buy)
Exercise: $20.27From: 2016-05-22Exp: 2022-05-22→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $34.40From: 2018-05-24Exp: 2024-05-24→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $50.50From: 2019-06-07Exp: 2025-06-07→ Common Stock (25,000 underlying)
25,000
Non-qualified stock options (right to buy)
Exercise: $52.17From: 2020-05-31Exp: 2026-05-31→ Common Stock (7,500 underlying)
7,500

Footnotes (9)

[F1]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.75 to $44.49, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F2]The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.46 to $44.40, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
[F3]Becomes exercisable in equal annual installments of 20% commencing 06/11/2015.
[F4]Becomes exercisable in equal annual installments of 20% commencing 05/22/2016.
[F5]Becomes exercisable in equal annual installments of 20% commencing 05/26/2017.
[F6]Becomes exercisable in equal annual installments of 20% commencing 05/24/2018.
[F7]Becomes exercisable in equal annual installments of 20% commencing 06/07/2019.
[F8]Becomes exercisable in equal annual installments of 33% commencing 05/24/2020.
[F9]Becomes exercisable in equal annual installments of 33% commencing 05/31/2020.

Documents

1 file

4
form4-05292020_120544.xmlPrimary

Issuer

MERIT MEDICAL SYSTEMS INC

CIK 0000856982

→

Entity typeother

Related Parties

filerCIK 0001534914

Filing Metadata

Form type: 4
Filed: May 28, 8:00 PM ET
Accepted: May 29, 3:46 PM ET
Size: 24.9 KB

View on SEC.gov